LAV Biosciences Fund V, L.P.

13D and 13G Filings

13D/G filings
13G on 1 security
Location
Grand Cayman, Cayman Islands
CIK
0001764435
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
ADARx Pharmaceuticals, Inc. 13G
ADRX · 00654F105
11.1% 10/16/2026
Event 9/30/2026

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.